Ligand Pharmaceuticals
LGND
LGND
211 hedge funds and large institutions have $2.08B invested in Ligand Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 71 increasing their positions, 77 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
211
Holders Change
-16
Holders Change %
-7.05%
% of All Funds
3.68%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
19
Increased
71
Reduced
77
Closed
35
Calls
$33.4M
Puts
$13.3M
Net Calls
+$20.1M
Net Calls Change
+$73.6M
Top Buyers
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$30.3M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$24.5M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$14.3M |
| 4 |
State Street
Boston,
Massachusetts
|
+$10.1M |
| 5 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
+$7.52M |
